 | • レポートコード：MRC2-11QY02496 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は前部ブドウ膜炎のグローバル市場について調査・分析したレポートです。種類別（角膜潰瘍、抗TNF剤、サイクロペジックス/毛様体筋弛緩薬）市場規模、用途別（病院、診療所、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別前部ブドウ膜炎の競争状況、市場シェア ・世界の前部ブドウ膜炎市場：種類別市場規模 2015年-2020年（角膜潰瘍、抗TNF剤、サイクロペジックス/毛様体筋弛緩薬） ・世界の前部ブドウ膜炎市場：種類別市場規模予測 2021年-2026年（角膜潰瘍、抗TNF剤、サイクロペジックス/毛様体筋弛緩薬） ・世界の前部ブドウ膜炎市場：用途別市場規模 2015年-2020年（病院、診療所、研究所） ・世界の前部ブドウ膜炎市場：用途別市場規模予測 2021年-2026年（病院、診療所、研究所） ・北米の前部ブドウ膜炎市場分析：米国、カナダ ・ヨーロッパの前部ブドウ膜炎市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの前部ブドウ膜炎市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の前部ブドウ膜炎市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの前部ブドウ膜炎市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amdipharm Mercury Company Limited、Novartis AG、Santen Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Anterior uveitis is an inflammation of the middle layer of the eye. This layer includes the iris (colored part of the eye) and the adjacent tissue, known as the ciliary body.
Geographically, the global anterior uveitis market is studied under five main regions namely North America, Latin America, Asia Pacific, Europe and MEA. The developed region such as North America and Europe is anticipated to witness increasing incidences of anterior uveitis compared to other developing nations like India, China, Brazil, Myanmar, Philippines, and other countries in Asia Pacific region. North America, Latin America, and Europe are more prone towards this disease followed by MEA and Asia Pacific due to their facilities and diagnosis of uveitis at earlier stage coupled with high level of awareness.
Market Analysis and Insights: Global Anterior Uveitis Market
The global Anterior Uveitis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anterior Uveitis Scope and Market Size
Anterior Uveitis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anterior Uveitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anterior Uveitis market is segmented into
Corneal Ulcers
Anti TNF Agents
Cyclopegics/ Ciliary Muscles Relaxants
Segment by Application, the Anterior Uveitis market is segmented into
Hospitals
Clinics
Research Institutes
Regional and Country-level Analysis
The Anterior Uveitis market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anterior Uveitis market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anterior Uveitis Market Share Analysis
Anterior Uveitis market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anterior Uveitis business, the date to enter into the Anterior Uveitis market, Anterior Uveitis product introduction, recent developments, etc.
The major vendors covered:
Amdipharm Mercury Company Limited
Novartis AG
Santen Pharmaceuticals
…
1 Study Coverage
1.1 Anterior Uveitis Product Introduction
1.2 Market Segments
1.3 Key Anterior Uveitis Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anterior Uveitis Market Size Growth Rate by Type
1.4.2 Corneal Ulcers
1.4.3 Anti TNF Agents
1.4.4 Cyclopegics/ Ciliary Muscles Relaxants
1.5 Market by Application
1.5.1 Global Anterior Uveitis Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anterior Uveitis Market Size, Estimates and Forecasts
2.1.1 Global Anterior Uveitis Revenue 2015-2026
2.1.2 Global Anterior Uveitis Sales 2015-2026
2.2 Global Anterior Uveitis, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anterior Uveitis Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anterior Uveitis Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anterior Uveitis Competitor Landscape by Players
3.1 Anterior Uveitis Sales by Manufacturers
3.1.1 Anterior Uveitis Sales by Manufacturers (2015-2020)
3.1.2 Anterior Uveitis Sales Market Share by Manufacturers (2015-2020)
3.2 Anterior Uveitis Revenue by Manufacturers
3.2.1 Anterior Uveitis Revenue by Manufacturers (2015-2020)
3.2.2 Anterior Uveitis Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anterior Uveitis Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anterior Uveitis Revenue in 2019
3.2.5 Global Anterior Uveitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anterior Uveitis Price by Manufacturers
3.4 Anterior Uveitis Manufacturing Base Distribution, Product Types
3.4.1 Anterior Uveitis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anterior Uveitis Product Type
3.4.3 Date of International Manufacturers Enter into Anterior Uveitis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anterior Uveitis Market Size by Type (2015-2020)
4.1.1 Global Anterior Uveitis Sales by Type (2015-2020)
4.1.2 Global Anterior Uveitis Revenue by Type (2015-2020)
4.1.3 Anterior Uveitis Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anterior Uveitis Market Size Forecast by Type (2021-2026)
4.2.1 Global Anterior Uveitis Sales Forecast by Type (2021-2026)
4.2.2 Global Anterior Uveitis Revenue Forecast by Type (2021-2026)
4.2.3 Anterior Uveitis Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anterior Uveitis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anterior Uveitis Market Size by Application (2015-2020)
5.1.1 Global Anterior Uveitis Sales by Application (2015-2020)
5.1.2 Global Anterior Uveitis Revenue by Application (2015-2020)
5.1.3 Anterior Uveitis Price by Application (2015-2020)
5.2 Anterior Uveitis Market Size Forecast by Application (2021-2026)
5.2.1 Global Anterior Uveitis Sales Forecast by Application (2021-2026)
5.2.2 Global Anterior Uveitis Revenue Forecast by Application (2021-2026)
5.2.3 Global Anterior Uveitis Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anterior Uveitis by Country
6.1.1 North America Anterior Uveitis Sales by Country
6.1.2 North America Anterior Uveitis Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anterior Uveitis Market Facts & Figures by Type
6.3 North America Anterior Uveitis Market Facts & Figures by Application
7 Europe
7.1 Europe Anterior Uveitis by Country
7.1.1 Europe Anterior Uveitis Sales by Country
7.1.2 Europe Anterior Uveitis Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anterior Uveitis Market Facts & Figures by Type
7.3 Europe Anterior Uveitis Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anterior Uveitis by Region
8.1.1 Asia Pacific Anterior Uveitis Sales by Region
8.1.2 Asia Pacific Anterior Uveitis Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anterior Uveitis Market Facts & Figures by Type
8.3 Asia Pacific Anterior Uveitis Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anterior Uveitis by Country
9.1.1 Latin America Anterior Uveitis Sales by Country
9.1.2 Latin America Anterior Uveitis Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anterior Uveitis Market Facts & Figures by Type
9.3 Central & South America Anterior Uveitis Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anterior Uveitis by Country
10.1.1 Middle East and Africa Anterior Uveitis Sales by Country
10.1.2 Middle East and Africa Anterior Uveitis Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anterior Uveitis Market Facts & Figures by Type
10.3 Middle East and Africa Anterior Uveitis Market Facts & Figures by Application
11 Company Profiles
11.1 Amdipharm Mercury Company Limited
11.1.1 Amdipharm Mercury Company Limited Corporation Information
11.1.2 Amdipharm Mercury Company Limited Description and Business Overview
11.1.3 Amdipharm Mercury Company Limited Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amdipharm Mercury Company Limited Anterior Uveitis Products Offered
11.1.5 Amdipharm Mercury Company Limited Related Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Description and Business Overview
11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis AG Anterior Uveitis Products Offered
11.2.5 Novartis AG Related Developments
11.3 Santen Pharmaceuticals
11.3.1 Santen Pharmaceuticals Corporation Information
11.3.2 Santen Pharmaceuticals Description and Business Overview
11.3.3 Santen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Santen Pharmaceuticals Anterior Uveitis Products Offered
11.3.5 Santen Pharmaceuticals Related Developments
11.1 Amdipharm Mercury Company Limited
11.1.1 Amdipharm Mercury Company Limited Corporation Information
11.1.2 Amdipharm Mercury Company Limited Description and Business Overview
11.1.3 Amdipharm Mercury Company Limited Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amdipharm Mercury Company Limited Anterior Uveitis Products Offered
11.1.5 Amdipharm Mercury Company Limited Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anterior Uveitis Market Estimates and Projections by Region
12.1.1 Global Anterior Uveitis Sales Forecast by Regions 2021-2026
12.1.2 Global Anterior Uveitis Revenue Forecast by Regions 2021-2026
12.2 North America Anterior Uveitis Market Size Forecast (2021-2026)
12.2.1 North America: Anterior Uveitis Sales Forecast (2021-2026)
12.2.2 North America: Anterior Uveitis Revenue Forecast (2021-2026)
12.2.3 North America: Anterior Uveitis Market Size Forecast by Country (2021-2026)
12.3 Europe Anterior Uveitis Market Size Forecast (2021-2026)
12.3.1 Europe: Anterior Uveitis Sales Forecast (2021-2026)
12.3.2 Europe: Anterior Uveitis Revenue Forecast (2021-2026)
12.3.3 Europe: Anterior Uveitis Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anterior Uveitis Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anterior Uveitis Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anterior Uveitis Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anterior Uveitis Market Size Forecast by Region (2021-2026)
12.5 Latin America Anterior Uveitis Market Size Forecast (2021-2026)
12.5.1 Latin America: Anterior Uveitis Sales Forecast (2021-2026)
12.5.2 Latin America: Anterior Uveitis Revenue Forecast (2021-2026)
12.5.3 Latin America: Anterior Uveitis Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anterior Uveitis Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anterior Uveitis Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anterior Uveitis Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anterior Uveitis Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anterior Uveitis Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anterior Uveitis Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anterior Uveitis Market Segments
Table 2. Ranking of Global Top Anterior Uveitis Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anterior Uveitis Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Corneal Ulcers
Table 5. Major Manufacturers of Anti TNF Agents
Table 6. Major Manufacturers of Cyclopegics/ Ciliary Muscles Relaxants
Table 7. Global Anterior Uveitis Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Anterior Uveitis Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Anterior Uveitis Sales by Regions 2015-2020 (K Units)
Table 10. Global Anterior Uveitis Sales Market Share by Regions (2015-2020)
Table 11. Global Anterior Uveitis Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Anterior Uveitis Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Anterior Uveitis Sales Share by Manufacturers (2015-2020)
Table 14. Global Anterior Uveitis Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Anterior Uveitis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anterior Uveitis as of 2019)
Table 16. Anterior Uveitis Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Anterior Uveitis Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Anterior Uveitis Price (2015-2020) (USD/Unit)
Table 19. Anterior Uveitis Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Anterior Uveitis Product Type
Table 21. Date of International Manufacturers Enter into Anterior Uveitis Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Anterior Uveitis Sales by Type (2015-2020) (K Units)
Table 24. Global Anterior Uveitis Sales Share by Type (2015-2020)
Table 25. Global Anterior Uveitis Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Anterior Uveitis Revenue Share by Type (2015-2020)
Table 27. Anterior Uveitis Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Anterior Uveitis Sales by Application (2015-2020) (K Units)
Table 29. Global Anterior Uveitis Sales Share by Application (2015-2020)
Table 30. North America Anterior Uveitis Sales by Country (2015-2020) (K Units)
Table 31. North America Anterior Uveitis Sales Market Share by Country (2015-2020)
Table 32. North America Anterior Uveitis Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Anterior Uveitis Revenue Market Share by Country (2015-2020)
Table 34. North America Anterior Uveitis Sales by Type (2015-2020) (K Units)
Table 35. North America Anterior Uveitis Sales Market Share by Type (2015-2020)
Table 36. North America Anterior Uveitis Sales by Application (2015-2020) (K Units)
Table 37. North America Anterior Uveitis Sales Market Share by Application (2015-2020)
Table 38. Europe Anterior Uveitis Sales by Country (2015-2020) (K Units)
Table 39. Europe Anterior Uveitis Sales Market Share by Country (2015-2020)
Table 40. Europe Anterior Uveitis Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Anterior Uveitis Revenue Market Share by Country (2015-2020)
Table 42. Europe Anterior Uveitis Sales by Type (2015-2020) (K Units)
Table 43. Europe Anterior Uveitis Sales Market Share by Type (2015-2020)
Table 44. Europe Anterior Uveitis Sales by Application (2015-2020) (K Units)
Table 45. Europe Anterior Uveitis Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Anterior Uveitis Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Anterior Uveitis Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Anterior Uveitis Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Anterior Uveitis Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Anterior Uveitis Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Anterior Uveitis Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Anterior Uveitis Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Anterior Uveitis Sales Market Share by Application (2015-2020)
Table 54. Latin America Anterior Uveitis Sales by Country (2015-2020) (K Units)
Table 55. Latin America Anterior Uveitis Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Anterior Uveitis Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Anterior Uveitis Revenue Market Share by Country (2015-2020)
Table 58. Latin America Anterior Uveitis Sales by Type (2015-2020) (K Units)
Table 59. Latin America Anterior Uveitis Sales Market Share by Type (2015-2020)
Table 60. Latin America Anterior Uveitis Sales by Application (2015-2020) (K Units)
Table 61. Latin America Anterior Uveitis Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Anterior Uveitis Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Anterior Uveitis Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Anterior Uveitis Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Anterior Uveitis Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Anterior Uveitis Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Anterior Uveitis Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Anterior Uveitis Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Anterior Uveitis Sales Market Share by Application (2015-2020)
Table 70. Amdipharm Mercury Company Limited Corporation Information
Table 71. Amdipharm Mercury Company Limited Description and Major Businesses
Table 72. Amdipharm Mercury Company Limited Anterior Uveitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Amdipharm Mercury Company Limited Product
Table 74. Amdipharm Mercury Company Limited Recent Development
Table 75. Novartis AG Corporation Information
Table 76. Novartis AG Description and Major Businesses
Table 77. Novartis AG Anterior Uveitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Novartis AG Product
Table 79. Novartis AG Recent Development
Table 80. Santen Pharmaceuticals Corporation Information
Table 81. Santen Pharmaceuticals Description and Major Businesses
Table 82. Santen Pharmaceuticals Anterior Uveitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Santen Pharmaceuticals Product
Table 84. Santen Pharmaceuticals Recent Development
Table 85. Global Anterior Uveitis Sales Forecast by Regions (2021-2026) (K Units)
Table 86. Global Anterior Uveitis Sales Market Share Forecast by Regions (2021-2026)
Table 87. Global Anterior Uveitis Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 88. Global Anterior Uveitis Revenue Market Share Forecast by Regions (2021-2026)
Table 89. North America: Anterior Uveitis Sales Forecast by Country (2021-2026) (K Units)
Table 90. North America: Anterior Uveitis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 91. Europe: Anterior Uveitis Sales Forecast by Country (2021-2026) (K Units)
Table 92. Europe: Anterior Uveitis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Asia Pacific: Anterior Uveitis Sales Forecast by Region (2021-2026) (K Units)
Table 94. Asia Pacific: Anterior Uveitis Revenue Forecast by Region (2021-2026) (US$ Million)
Table 95. Latin America: Anterior Uveitis Sales Forecast by Country (2021-2026) (K Units)
Table 96. Latin America: Anterior Uveitis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Middle East and Africa: Anterior Uveitis Sales Forecast by Country (2021-2026) (K Units)
Table 98. Middle East and Africa: Anterior Uveitis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 100. Key Challenges
Table 101. Market Risks
Table 102. Main Points Interviewed from Key Anterior Uveitis Players
Table 103. Anterior Uveitis Customers List
Table 104. Anterior Uveitis Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Anterior Uveitis Product Picture
Figure 2. Global Anterior Uveitis Sales Market Share by Type in 2020 & 2026
Figure 3. Corneal Ulcers Product Picture
Figure 4. Anti TNF Agents Product Picture
Figure 5. Cyclopegics/ Ciliary Muscles Relaxants Product Picture
Figure 6. Global Anterior Uveitis Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Research Institutes
Figure 10. Anterior Uveitis Report Years Considered
Figure 11. Global Anterior Uveitis Market Size 2015-2026 (US$ Million)
Figure 12. Global Anterior Uveitis Sales 2015-2026 (K Units)
Figure 13. Global Anterior Uveitis Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Anterior Uveitis Sales Market Share by Region (2015-2020)
Figure 15. Global Anterior Uveitis Sales Market Share by Region in 2019
Figure 16. Global Anterior Uveitis Revenue Market Share by Region (2015-2020)
Figure 17. Global Anterior Uveitis Revenue Market Share by Region in 2019
Figure 18. Global Anterior Uveitis Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Anterior Uveitis Revenue in 2019
Figure 20. Anterior Uveitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Anterior Uveitis Sales Market Share by Type (2015-2020)
Figure 22. Global Anterior Uveitis Sales Market Share by Type in 2019
Figure 23. Global Anterior Uveitis Revenue Market Share by Type (2015-2020)
Figure 24. Global Anterior Uveitis Revenue Market Share by Type in 2019
Figure 25. Global Anterior Uveitis Market Share by Price Range (2015-2020)
Figure 26. Global Anterior Uveitis Sales Market Share by Application (2015-2020)
Figure 27. Global Anterior Uveitis Sales Market Share by Application in 2019
Figure 28. Global Anterior Uveitis Revenue Market Share by Application (2015-2020)
Figure 29. Global Anterior Uveitis Revenue Market Share by Application in 2019
Figure 30. North America Anterior Uveitis Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Anterior Uveitis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Anterior Uveitis Sales Market Share by Country in 2019
Figure 33. North America Anterior Uveitis Revenue Market Share by Country in 2019
Figure 34. U.S. Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Anterior Uveitis Market Share by Type in 2019
Figure 39. North America Anterior Uveitis Market Share by Application in 2019
Figure 40. Europe Anterior Uveitis Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Anterior Uveitis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Anterior Uveitis Sales Market Share by Country in 2019
Figure 43. Europe Anterior Uveitis Revenue Market Share by Country in 2019
Figure 44. Germany Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Anterior Uveitis Market Share by Type in 2019
Figure 55. Europe Anterior Uveitis Market Share by Application in 2019
Figure 56. Asia Pacific Anterior Uveitis Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Anterior Uveitis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Anterior Uveitis Sales Market Share by Region in 2019
Figure 59. Asia Pacific Anterior Uveitis Revenue Market Share by Region in 2019
Figure 60. China Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Anterior Uveitis Market Share by Type in 2019
Figure 83. Asia Pacific Anterior Uveitis Market Share by Application in 2019
Figure 84. Latin America Anterior Uveitis Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Anterior Uveitis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Anterior Uveitis Sales Market Share by Country in 2019
Figure 87. Latin America Anterior Uveitis Revenue Market Share by Country in 2019
Figure 88. Mexico Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Anterior Uveitis Market Share by Type in 2019
Figure 95. Latin America Anterior Uveitis Market Share by Application in 2019
Figure 96. Middle East and Africa Anterior Uveitis Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Anterior Uveitis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Anterior Uveitis Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Anterior Uveitis Revenue Market Share by Country in 2019
Figure 100. Turkey Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Anterior Uveitis Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Anterior Uveitis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Anterior Uveitis Market Share by Type in 2019
Figure 107. Middle East and Africa Anterior Uveitis Market Share by Application in 2019
Figure 108. North America Anterior Uveitis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Anterior Uveitis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Anterior Uveitis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Anterior Uveitis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Anterior Uveitis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Anterior Uveitis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Anterior Uveitis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Anterior Uveitis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Anterior Uveitis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Anterior Uveitis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
ブドウ膜炎治療の世界市場（～2026年） Uveitis is considered to be the leading cause for blindness in the U.S. with a gradual rise in prevalence. North America and APAC regions expected to be major contributors in the expansion of the global uveitis treatment market. Market Analysis and Insights: Global Uveitis Treatment Market The globa…- 直接前方アプローチの世界市場（～2026年） Osteoarthritis is one of the prime reasons for aggravating hip pain in the elderly. Direct anterior approach (DAA) is a minimally invasive surgery made possible with a small incision without cutting any tendons. This technique has benefits such as low surgery time, reduced post-surgery pain, and rap…
- 直接前股関節置換術の世界市場（～2026年） A hip replacement is an invasive surgical procedure, used to remove a diseased or fractured hip joint and replace it with an artificial joint or prosthesis. Osteoarthritis is one of the most common factors for hip diseases. Structures within the hip (such as the cartilage or bony joint surfaces) may…
- 強膜炎の世界市場（～2026年） Sclera is the outer layer of the eye. Scleritis is a disorder in which the sclera severely becomes red and inflamed. Globally North America is the largest market for Scleritis. Europe is the second-largest market and Asia Pacific is expected to grow at a rapid rate. Market Analysis and Insights: Glo…
- 原発性線毛機能不全の世界市場（～2026年） Primary ciliary dyskinesia (PCD), also called immotile ciliary syndrome or Kartagener syndrome, is a rare, ciliopathic, autosomal recessive genetic disorder that causes defects in the action of cilia lining the respiratory tract (lower and upper, sinuses, Eustachian tube, middle ear), fallopian tube…